Yasemin Erten

Prof. Dr. Yasemin Erten


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Veysel Baran TomarVeysel Baran Tomar
Veysel Baran Tomar
OAOmer Faruk Akcay
Omer Faruk Akcay
ADAsil Demirezen
Asil Demirezen
TCTaha Enes Cetin
Taha Enes Cetin
AHAyser Seda Hasdemir
Ayser Seda Hasdemir
YEYasemin Erten
Yasemin Erten
Background/Objectives: Peritoneal membrane failure remains a major limitation of peritoneal dialysis (PD). Systemic inflammation contributes to membrane dysfunction, yet simple predictive biomarkers are lacking. The uric acid-to-HDL cholesterol ratio (UHR) represents a novel integrative marker of metabolic-inflammatory burden, but its association with membrane failure has not been investigated. Methods: This retrospective cohort study included adult patients who initiated PD between 1997 and 2023. Baseline UHR was calculated from laboratory measurements obtained within the first three months after PD initiation. The primary outcome was peritoneal membrane failure, defined as permanent transfer to hemodialysis due to ultrafiltration failure, inadequate solute clearance, or progressive membrane dysfunction. Receiver operating characteristic, Kaplan–Meier, and Cox regression analyses were used to evaluate the association between UHR and membrane failure. Results: Among 214 patients, 62 (29%) developed membrane failure during follow-up. Baseline UHR was significantly higher in patients with membrane failure. A UHR cut-off value of 14 was identified for risk stratification. In multivariable Cox regression analysis, UHR >14 was independently associated with an increased risk of membrane failure (hazard ratio 1.836, 95% CI 1.040–3.241). A history of kidney transplantation prior to PD initiation also emerged as a strong independent predictor of membrane failure. Conclusions: Elevated baseline UHR is independently associated with peritoneal membrane failure in PD patients. As a simple and readily available biomarker, UHR may support early risk stratification and individualized management. Prospective multicenter studies are warranted to validate these findings.

12 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Veysel Baran TomarVeysel Baran Tomar
Veysel Baran Tomar
OAOmer Faruk Akcay
Omer Faruk Akcay
ADAsil Demirezen
Asil Demirezen
TCTaha Enes Cetin
Taha Enes Cetin
AHAyser Seda Hasdemir
Ayser Seda Hasdemir
YEYasemin Erten
Yasemin Erten
Peritoneal membrane–related technical failure remains a major limitation of peritoneal dialysis (PD), yet simple predictive biomarkers are lacking. The uric acid–to–HDL cholesterol ratio (UHR) is an integrative marker of metabolic-inflammatory burden. This retrospective cohort study included 214 adult patients who initiated PD between 1997-2025 at a tertiary center. Baseline UHR was calculated from laboratory measurements obtained within three months after PD initiation. The primary outcome was peritoneal membrane–related technical failure, defined as permanent transfer to hemodialysis due to ultrafiltration failure, inadequate solute clearance, or progressive membrane dysfunction. Among 214 patients, 62 (29%) developed membrane failure during follow-up. A UHR cut-off value of 14 was identified by ROC analysis (AUC 0.644). In multivariable Cox regression, UHR >14 was independently associated with increased risk of membrane failure (HR 1.836, 95% CI 1.040–3.241, p = 0.036). A history of kidney transplantation prior to PD initiation also emerged as a strong independent predictor (HR 3.971, 95% CI 1.668–9.455, p = 0.002). Elevated baseline UHR is independently associated with peritoneal membrane–related technical failure. As a simple, inexpensive, and routinely available biomarker, UHR may support early risk stratification and individualized management in PD patients.